Vanda Pharma (VNDA) Tops by 3c, Posts Q3 Loss of $0.28
More News related to VNDA
- Semi-Annual Changes to the NASDAQ Biotechnology Index
- Vanda Pharma (VNDA) Tops by 3c, Posts Q3 Loss of $0.28
- Vanda Pharmaceuticals Reports Third Quarter 2009 Results
- Vanda Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 2, 2009
- Vanda (VNDA) and Novartis (NVS) to Develop Fanapt in US and Canada
More News related to Earnings
- First Financial Service Corp. (FFKY) To Suspend Cash Dividends to Preserve Capital
- GM said to consider shutting down Saab brand without a buyer
- Highlights From Brocade Communications's (BRCD) Q4 Q&A Session; Reaffirms FY10 Outlook
- Converted Organics (COIN) Appoints Garrett and Knight to Sales Reps in NE and SE U.S.
- GM's sale of Saab is off -CNBC
Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) reports Q3 loss of $0.28, 3 cents better than the analyst estimate of ($0.31).
Related Categories
EarningsStocks Mentioned
-0.06Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
